Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Making It Personal

I'll admit, I was taken back by your posts last week because you did respond as if I offended you in some way. Your repsonses were, without a doubt, very hostile.

As I've tried to explain on numerous occasions, I've read approximately 3 critical articles on Patriot written by fairly well known analysts/financial writers. (I'm sure you've read these articles as well.) These articles all state that not having any additional revenue streams is a problem for Patriot. No offense, but these writers have a lot more effect on the SP and carry a lot more weight than you do.

Get real(?) - sorry but there are ways to create substantial revenue streams with the kind of money that Patriot is accumulating - company's do it all the time - do you read the WSJ? The truth is, we don't really know what they're doing with Holocom or Ignite and that is a problem. They could be working on something great or they could be doing nothing at all.

The one thing we do actually know about isn't very good and is a "bigger" problem - and you brought it up: "While I would agree that issuing divys isn't the wisest use of the money IMO," - ISN'T THE WISEST USE OF THE MONEY IMO????? Here's where I get frustrated. Your statement regarding the divys is a bit of an "understatement" wouldn't you say? Issuing divys is actually one of the dumbest things they could do with the money and makes Patriot look extremely shady - hense our low share price. Any small company actually trying to make a go of it obviously wouldn't do something like this.

SG E - there are several of the regulars on this board who state the very same things as I do about additional revenue streams but you obviously don't mind when they bring it up. This click/fraternity mentality is what is frustrating to me.

Share
New Message
Please login to post a reply